Bluebird Bio secures up to $175M in debt financing with Hercules Capital to extend its cash runway beyond the next 24 months.
Amount Raised
$175 Million
Round Type
Debt Financing
SomervilleBiotechnologyHealth CareTherapeuticsInvestors
Description
Bluebird Bio has secured up to $175 million in debt financing with Hercules Capital in a five-year term loan facility, which provides for the funds in separate tranches. The firm anticipates that the funding will extend its cash runway beyond the next 24 months.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as bluebird bio that raised within 45 days of this round, from Fundz verified event records.
- Scipher Medicine raised $25M on May 2, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
- Delphia Therapeutics raised $67M (Series A) on May 2, 2024.
- Medicenna raised $15M on April 30, 2024.
- Cerevance raised $47M (Series B) on April 29, 2024.
- Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
Who to call at bluebird bio, and when
A new round usually means bluebird bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day bluebird bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at bluebird bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at bluebird bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment bluebird bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
bluebird bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.